BPMC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 4.21%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,438,120.10

Blueprint Medicines Insider Trading History Chart

Blueprint Medicines Share Price & Price History

^$129.46

+0.30 (1.20%)

As of 07/18/2025 01:00 AM ET

Blueprint Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/3/2025	Percy H. Carter	Insider	Sell	1,051	$128.25	$134,790.75	53,155
5/27/2025	Jeffrey W. Albers	Director	Sell	5,000	$101.14	$505,700.00	146,630
5/19/2025	Christina Rossi	COO	Sell	2,274	$100.51	$228,559.74	64,718
5/5/2025	Ariel Hurley	Insider	Sell	2,752	$103.13	$283,813.76	16,944
5/5/2025	Christina Rossi	COO	Sell	2,274	$101.75	$231,379.50	66,992
3/24/2025	Christina Rossi	COO	Sell	2,274	$95.02	$216,075.48	69,266
3/3/2025	Ariel Hurley	Insider	Sell	3,203	$92.62	$296,661.86	18,270
1/21/2025	Christina Rossi	COO	Sell	2,274	$110.14	$250,458.36	67,109
1/21/2025	Jeffrey W. Albers	Director	Sell	15,161	$109.53	$1,660,584.33	152,396
1/21/2025	Kate Haviland	CEO	Sell	1,446	$110.24	$159,407.04	149,378
1/13/2025	Ariel Hurley	Insider	Sell	2,250	$100.00	$225,000.00	14,967
1/13/2025	Jeffrey W. Albers	Director	Sell	5,000	$102.28	$511,400.00	157,557
12/19/2024	Jeffrey W. Albers	Director	Sell	15,000	$89.77	$1,346,550.00	157,557
12/18/2024	Christina Rossi	COO	Sell	2,274	$95.91	$218,099.34	69,383
12/12/2024	Ariel Hurley	Insider	Sell	1,819	$93.26	$169,639.94	14,967
11/29/2024	Kate Haviland	CEO	Sell	2,353	$96.60	$227,299.80	150,824
11/27/2024	Christina Rossi	COO	Sell	2,274	$95.10	$216,257.40	71,657
10/3/2024	Fouad Namouni	Insider	Sell	3,633	$89.32	$324,499.56	69,070
8/5/2024	Philina Lee	Insider	Sell	41,913	$93.19	$3,905,872.47	34,729
7/5/2024	Debra Durso-Bumpus	Insider	Sell	3,850	$111.20	$428,120.00	43,763
7/3/2024	Debra Durso-Bumpus	Insider	Sell	8,817	$111.29	$981,243.93	43,763
6/28/2024	Debra Durso-Bumpus	Insider	Sell	333	$111.15	$37,012.95	43,763
6/21/2024	Debra Durso-Bumpus	Insider	Sell	74,034	$104.19	$7,713,602.46	43,763
6/5/2024	Percy H. Carter	Insider	Sell	4,000	$105.13	$420,520.00	41,895
6/3/2024	L. Becker Hewes	Insider	Sell	4,922	$106.43	$523,848.46	31,938
5/31/2024	L. Becker Hewes	Insider	Sell	34,108	$105.91	$3,612,378.28	36,860
5/2/2024	Ariel Hurley	Insider	Sell	1,834	$103.88	$190,515.92	14,913
5/2/2024	Michael Landsittel	CFO	Sell	10,000	$105.00	$1,050,000.00	47,286
3/28/2024	Michael Landsittel	CFO	Sell	5,000	$95.00	$475,000.00	47,286
3/20/2024	Jeffrey W. Albers	Director	Sell	25,073	$87.28	$2,188,371.44	176,050
3/15/2024	Michael Landsittel	CFO	Sell	13,734	$87.78	$1,205,570.52	47,286
3/7/2024	Christina Rossi	COO	Sell	6,070	$90.69	$550,488.30	64,306
3/7/2024	Jeffrey W. Albers	Director	Sell	11,033	$90.69	$1,000,582.77	165,017
3/7/2024	Kate Haviland	CEO	Sell	12,464	$90.69	$1,130,360.16	153,177
3/7/2024	L. Becker Hewes	Insider	Sell	3,097	$90.69	$280,866.93	46,281
3/7/2024	Michael Landsittel	CFO	Sell	5,003	$90.69	$453,722.07	56,020
3/7/2024	Tracey L. Mccain	EVP	Sell	5,194	$90.69	$471,043.86	60,498
3/4/2024	Christopher K. Murray	Insider	Sell	621	$93.65	$58,156.65	36,374
2/28/2024	Christopher K. Murray	Insider	Sell	5,000	$100.00	$500,000.00	24,495
1/25/2024	Jeffrey W. Albers	Director	Sell	25,000	$81.91	$2,047,750.00	176,050
12/22/2023	Ariel Hurley	Insider	Sell	714	$90.00	$64,260.00	14,324
12/7/2023	Christopher K. Murray	Insider	Sell	5,000	$75.00	$375,000.00	24,495
12/4/2023	Christopher K. Murray	Insider	Sell	600	$71.43	$42,858.00	24,495
11/30/2023	Jeffrey W. Albers	Director	Sell	5,000	$70.55	$352,750.00	176,050
11/24/2023	Jeffrey W. Albers	Director	Sell	15,000	$67.51	$1,012,650.00	176,050
11/3/2023	Jeffrey W. Albers	Director	Sell	1,485	$60.13	$89,293.05	176,050
11/1/2023	Jeffrey W. Albers	Director	Sell	3,881	$60.02	$232,937.62	176,050
10/26/2023	Christopher K. Murray	Insider	Sell	600	$56.40	$33,840.00	25,095
10/4/2023	Fouad Namouni	Insider	Sell	3,769	$48.06	$181,138.14	62,080
9/28/2023	Jeffrey W. Albers	Director	Sell	6,898	$50.17	$346,072.66	176,050
8/25/2023	Jeffrey W. Albers	Director	Sell	10,000	$50.16	$501,600.00	176,050
6/5/2023	Percy H. Carter	Insider	Sell	2,307	$52.06	$120,102.42	38,117
3/6/2023	Christina Rossi	COO	Sell	3,059	$45.67	$139,704.53	55,376
3/6/2023	Christopher K. Murray	Insider	Sell	1,875	$45.68	$85,650.00	25,695
3/6/2023	Jeffrey W. Albers	Director	Sell	9,793	$45.67	$447,246.31	173,450
3/6/2023	Kate Haviland	CEO	Sell	6,640	$45.69	$303,381.60	125,641
3/6/2023	Michael Landsittel	CFO	Sell	3,007	$45.68	$137,359.76	48,523
3/6/2023	Tracey L. Mccain	EVP	Sell	3,322	$45.68	$151,748.96	52,666
12/5/2022	Jeffrey W. Albers	Director	Sell	20,000	$50.09	$1,001,800.00	183,243

SEC Filings (Institutional Ownership Changes) for Blueprint Medicines (NASDAQ:BPMC)

Institutional Buying and Selling by Quarter

Blueprint Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/4/2025	Osaic Holdings Inc.	278	$35K	0.0%	-83.2%	0.000%
8/28/2025	China Universal Asset Management Co. Ltd.	12,971	$1.66M	0.2%	+1.2%	0.020%
8/19/2025	Pitcairn Co.	4,744	$0.61M	0.0%	-57.1%	0.007%
8/18/2025	Hudson Bay Capital Management LP	129,398	$16.59M	0.1%	N/A	0.200%
8/16/2025	FORA Capital LLC	12,589	$1.61M	0.2%	N/A	0.019%
8/15/2025	CANADA LIFE ASSURANCE Co	14,186	$1.82M	0.0%	+86.1%	0.022%
8/15/2025	Tower Research Capital LLC TRC	6,527	$0.84M	0.0%	-20.2%	0.010%
8/15/2025	E Fund Management Co. Ltd.	6,761	$0.87M	0.0%	-27.2%	0.010%
8/15/2025	Water Island Capital LLC	116,631	$14.95M	2.1%	N/A	0.181%
8/15/2025	Taconic Capital Advisors LP	45,000	$5.77M	0.5%	N/A	0.070%
8/15/2025	Rafferty Asset Management LLC	60,567	$7.76M	0.0%	-39.0%	0.094%
8/15/2025	Rangeley Capital LLC	5,000	$0.64M	0.8%	N/A	0.008%
8/15/2025	Orion Investment Co	106,134	$13.60M	4.8%	-2.7%	0.164%
8/15/2025	Moore Capital Management LP	20,000	$2.56M	0.0%	N/A	0.031%
8/15/2025	Man Group plc	516,258	$66.17M	0.1%	-0.7%	0.799%
8/15/2025	Lazard Asset Management LLC	1,348	$0.17M	0.0%	-92.2%	0.002%
8/15/2025	LMR Partners LLP	395,857	$50.74M	0.4%	+3,603.4%	0.613%
8/15/2025	HRT Financial LP	69,916	$8.96M	0.0%	N/A	0.108%
8/15/2025	Hudson Bay Capital Management LP	129,398	$16.59M	0.1%	N/A	0.200%
8/15/2025	Eventide Asset Management LLC	728,821	$93.42M	1.6%	-15.5%	1.129%
8/15/2025	Engineers Gate Manager LP	5,400	$0.69M	0.0%	-78.1%	0.008%
8/15/2025	Cubist Systematic Strategies LLC	46,602	$5.97M	0.0%	N/A	0.072%
8/15/2025	BNP Paribas Financial Markets	18,556	$2.38M	0.0%	+268.8%	0.029%
8/15/2025	BTG Pactual Asset Management US LLC	5,000	$0.64M	0.1%	N/A	0.008%
8/15/2025	Bellevue Group AG	284,900	$36.52M	0.8%	N/A	0.441%
8/15/2025	Beryl Capital Management LLC	1,067,224	$136.80M	20.6%	N/A	1.653%
8/15/2025	Balyasny Asset Management L.P.	505,957	$64.85M	0.1%	+739.3%	0.783%
8/15/2025	Bank of America Corp DE	647,487	$83M	0.0%	-9.7%	1.003%
8/15/2025	Adage Capital Partners GP L.L.C.	50,000	$6.41M	0.0%	N/A	0.077%
8/15/2025	Ameriprise Financial Inc.	18,199	$2.33M	0.0%	-95.0%	0.028%
8/15/2025	AQR Capital Management LLC	92,469	$11.85M	0.0%	-37.6%	0.143%
8/15/2025	AQR Arbitrage LLC	80,179	$10.28M	0.2%	N/A	0.124%
8/14/2025	PDT Partners LLC	34,271	$4.39M	0.2%	+462.0%	0.053%
8/14/2025	Whitebox Advisors LLC	310,001	$39.74M	0.8%	N/A	0.480%
8/14/2025	California State Teachers Retirement System	63,898	$8.19M	0.0%	+9.1%	0.099%
8/14/2025	Raymond James Financial Inc.	66,461	$8.52M	0.0%	-65.7%	0.103%
8/14/2025	Canada Pension Plan Investment Board	49,400	$6.33M	0.0%	+8.6%	0.076%
8/14/2025	Soros Fund Management LLC	250,000	$32.05M	0.4%	N/A	0.387%
8/14/2025	Bayesian Capital Management LP	33,300	$4.27M	0.7%	N/A	0.052%
8/14/2025	Alliancebernstein L.P.	765,387	$98.11M	0.0%	-36.0%	1.185%
8/14/2025	The Manufacturers Life Insurance Company	74,708	$9.58M	0.0%	-54.5%	0.116%
8/14/2025	Squarepoint Ops LLC	130,066	$16.67M	0.0%	+418.1%	0.201%
8/14/2025	Sei Investments Co.	28,131	$3.61M	0.0%	-60.2%	0.044%
8/14/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,713,587	$219.65M	11.3%	+35,122.8%	2.653%
8/14/2025	Harvest Management LLC	95,000	$12.18M	5.2%	N/A	0.147%
8/14/2025	Frontier Capital Management Co. LLC	21,687	$2.78M	0.0%	-49.5%	0.034%
8/14/2025	Qube Research & Technologies Ltd	66,275	$8.50M	0.0%	-80.3%	0.103%
8/14/2025	State Street Corp	2,230,980	$285.97M	0.0%	-16.9%	3.454%
8/14/2025	Vega Investment Solutions	310	$40K	0.0%	-48.1%	0.000%
8/14/2025	California Public Employees Retirement System	86,709	$11.11M	0.0%	+11.8%	0.134%
8/14/2025	Cerity Partners LLC	5,035	$0.65M	0.0%	+8.8%	0.008%
8/13/2025	Gabelli Funds LLC	211,169	$27.07M	0.2%	N/A	0.327%
8/13/2025	GABELLI & Co INVESTMENT ADVISERS INC.	183,374	$23.51M	3.6%	N/A	0.284%
8/13/2025	Gamco Investors INC. ET AL	7,000	$0.90M	0.0%	N/A	0.011%
8/13/2025	Jump Financial LLC	147,325	$18.88M	0.2%	N/A	0.228%
8/13/2025	Affinity Asset Advisors LLC	250,000	$32.05M	4.4%	N/A	0.387%
8/13/2025	Capula Management Ltd	156,114	$20.01M	0.2%	N/A	0.242%
8/13/2025	Diametric Capital LP	2,777	$0.36M	0.2%	N/A	0.004%
8/13/2025	Brown Advisory Inc.	458,559	$58.78M	0.1%	-21.2%	0.710%
8/13/2025	Marshall Wace LLP	31,900	$4.09M	0.0%	+200.9%	0.049%
8/13/2025	First Trust Advisors LP	39,783	$5.10M	0.0%	+1,151.0%	0.062%
8/13/2025	Kennedy Capital Management LLC	4,836	$0.62M	0.0%	+4.6%	0.007%
8/13/2025	EverSource Wealth Advisors LLC	315	$40K	0.0%	+65.8%	0.000%
8/13/2025	Guggenheim Capital LLC	14,624	$1.88M	0.0%	+5.8%	0.023%
8/13/2025	Invesco Ltd.	511,091	$65.51M	0.0%	-48.1%	0.791%
8/13/2025	Groupe la Francaise	94,150	$12.07M	0.2%	N/A	0.146%
8/13/2025	Arrowstreet Capital Limited Partnership	29,562	$3.79M	0.0%	N/A	0.046%
8/13/2025	NBW Capital LLC	33,703	$4.32M	0.9%	-2.8%	0.052%
8/13/2025	Quantbot Technologies LP	5,848	$0.75M	0.0%	N/A	0.009%
8/13/2025	Fisher Asset Management LLC	7,459	$0.96M	0.0%	-97.6%	0.012%
8/13/2025	Panagora Asset Management Inc.	149,440	$19.16M	0.1%	-27.3%	0.231%
8/13/2025	New York State Common Retirement Fund	20,920	$2.68M	0.0%	+5.5%	0.032%
8/13/2025	Skandinaviska Enskilda Banken AB publ	11,500	$1.47M	0.0%	N/A	0.018%
8/13/2025	Norges Bank	1,074,936	$137.79M	0.0%	N/A	1.664%
8/13/2025	NINE MASTS CAPITAL Ltd	6,000	$0.77M	0.2%	N/A	0.009%
8/13/2025	Quadrature Capital Ltd	382,677	$49.06M	0.8%	N/A	0.593%
8/13/2025	Hsbc Holdings PLC	3,409	$0.44M	0.0%	-67.6%	0.005%
8/13/2025	Elevation Point Wealth Partners LLC	231	$30K	0.0%	N/A	0.000%
8/13/2025	Russell Investments Group Ltd.	34,201	$4.38M	0.0%	-79.8%	0.053%
8/12/2025	Advisors Asset Management Inc.	5,453	$0.70M	0.0%	-1.8%	0.008%
8/12/2025	Picton Mahoney Asset Management	170,000	$21.79M	0.2%	+78,241.0%	0.263%
8/12/2025	Eisler Capital Management Ltd.	78,198	$10.02M	0.1%	N/A	0.121%
8/12/2025	Prudential Financial Inc.	83,973	$10.76M	0.0%	-10.2%	0.130%
8/12/2025	American Century Companies Inc.	22,770	$2.92M	0.0%	-97.4%	0.035%
8/12/2025	Rhumbline Advisers	99,649	$12.77M	0.0%	+8.4%	0.154%
8/12/2025	Franklin Resources Inc.	173,510	$22.24M	0.0%	+27.5%	0.269%
8/12/2025	Legal & General Group Plc	99,224	$12.72M	0.0%	+3.7%	0.154%
8/12/2025	Hillsdale Investment Management Inc.	63,000	$8.08M	0.3%	+20.2%	0.098%
8/12/2025	Entropy Technologies LP	8,722	$1.12M	0.1%	N/A	0.014%
8/12/2025	Magnetar Financial LLC	730,047	$93.58M	0.5%	+15,881.8%	1.130%
8/12/2025	Swiss National Bank	122,000	$15.64M	0.0%	-0.9%	0.189%
8/12/2025	Highbridge Capital Management LLC	189,822	$24.33M	1.0%	N/A	0.294%
8/12/2025	Handelsbanken Fonder AB	17,651	$2.26M	0.0%	-5.4%	0.027%
8/12/2025	Ensign Peak Advisors Inc	32,500	$4.17M	0.0%	-89.3%	0.050%
8/11/2025	Greenland Capital Management LP	9,562	$1.23M	0.1%	N/A	0.015%
8/11/2025	Intrust Bank NA	4,382	$0.56M	0.0%	+23.2%	0.007%
8/11/2025	Universal Beteiligungs und Servicegesellschaft mbH	41,571	$5.33M	0.0%	-51.0%	0.064%
8/11/2025	Mint Tower Capital Management B.V.	15,000	$1.92M	0.3%	N/A	0.023%
8/8/2025	Alberta Investment Management Corp	60,000	$7.69M	0.1%	N/A	0.093%
8/8/2025	Intech Investment Management LLC	31,834	$4.08M	0.0%	-20.4%	0.049%

Data available starting January 2016

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered thyroid carcinoma, and medullary thyroid carcinoma; BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $129.46

$129.46

50 Day Range

MA: $128.90

$127.95

$129.48

52 Week Range

Now: $129.46

$73.04

$129.65

Volume

N/A

Average Volume

1,547,506 shs

Market Capitalization

$8.36 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

Who are the company insiders with the largest holdings of Blueprint Medicines?: Blueprint Medicines' top insider investors include:
Jeffrey W Albers (Director)
Kate Haviland (CEO)
Christina Rossi (COO)
Fouad Namouni (Insider)
Tracey L Mccain (EVP)
Michael Landsittel (CFO)
Percy H Carter (Insider)
L Becker Hewes (Insider)
Debra Durso-Bumpus (Insider)
Christopher K Murray (Insider)
Philina Lee (Insider)
Ariel Hurley (Insider)
Learn More about top insider investors at Blueprint Medicines.
Who are the major institutional investors of Blueprint Medicines?: Blueprint Medicines' top institutional investors include:
Susquehanna International Group LLP — 0.00%
Millennium Management LLC — 0.00%
Citadel Advisors LLC — 0.00%
Caption Management LLC — 0.00%
Capital Fund Management S.A. — 0.00%
Group One Trading LLC — 0.00%
Learn More about top institutional investors of Blueprint Medicines stock.
Which major investors are selling Blueprint Medicines stock?: In the previous quarter, BPMC stock was sold by these institutional investors:
Susquehanna International Group LLP
Equitec Proprietary Markets LLC
Caption Management LLC
Group One Trading LLC
Citadel Advisors LLC
Millennium Management LLC
Capital Fund Management S.A.
Garda Capital Partners LP
Within the last year, company insiders that have sold Blueprint Medicines company stock include:
Jeffrey W Albers (Director)
Kate Haviland (CEO)
Christina Rossi (COO)
Fouad Namouni (Insider)
Tracey L Mccain (EVP)
Learn More investors selling Blueprint Medicines stock.